CCL2 and Alzheimer disease: Patients with AD exhibited an increase in inflammatory biomarkers including peripheral blood natural killer cells, B cells, regulatory T cells, C-reactive proteins, and cytokines such as IL-6 and IL-8, TNF-α, and C-C motif chemokine ligand 2 (CCL2) [4].